These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34097884)

  • 1. P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases.
    Mishra A; Behura A; Kumar A; Naik L; Swain A; Das M; Sarangi SS; Dokania P; Dirisala VR; Bhutia SK; Mishra A; Singh R; Dhiman R
    Eur J Pharmacol; 2021 Sep; 906():174235. PubMed ID: 34097884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer.
    Bae JY; Lee SW; Shin YH; Lee JH; Jahng JW; Park K
    Oncotarget; 2017 Jul; 8(30):48972-48982. PubMed ID: 28430665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X
    Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S
    J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X7 Receptor as a Therapeutic Target.
    De Marchi E; Orioli E; Dal Ben D; Adinolfi E
    Adv Protein Chem Struct Biol; 2016; 104():39-79. PubMed ID: 27038372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7 receptor and the NLRP3 inflammasome: Partners in crime.
    Pelegrin P
    Biochem Pharmacol; 2021 May; 187():114385. PubMed ID: 33359010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The P2X7 receptor: A main player in inflammation.
    Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
    Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P2X7 Receptor in Infection and Inflammation.
    Di Virgilio F; Dal Ben D; Sarti AC; Giuliani AL; Falzoni S
    Immunity; 2017 Jul; 47(1):15-31. PubMed ID: 28723547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome activation in bovine monocytes by extracellular ATP does not require the purinergic receptor P2X7.
    Hussen J; Düvel A; Koy M; Schuberth HJ
    Dev Comp Immunol; 2012 Oct; 38(2):312-20. PubMed ID: 22728096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
    Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
    J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver kinase B1/AMP-activated protein kinase-mediated regulation by gentiopicroside ameliorates P2X7 receptor-dependent alcoholic hepatosteatosis.
    Li X; Zhang Y; Jin Q; Xia KL; Jiang M; Cui BW; Wu YL; Song SZ; Lian LH; Nan JX
    Br J Pharmacol; 2018 May; 175(9):1451-1470. PubMed ID: 29338075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease.
    Shokoples BG; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):186-199. PubMed ID: 32998520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
    Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
    Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ligand-gated ion channel P2X7 receptor mediates NLRP3/caspase-1-mediated pyroptosis in cerebral cortical neurons of juvenile rats with sepsis.
    Sun X; Zhou R; Lei Y; Hu J; Li X
    Brain Res; 2020 Dec; 1748():147109. PubMed ID: 32905819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
    J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X7 receptor in cardiovascular disease: The heart side.
    Guerra Martinez C
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):513-526. PubMed ID: 30834550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic receptors: new targets for the treatment of gout and fibrosis.
    Gicquel T; Le Daré B; Boichot E; Lagente V
    Fundam Clin Pharmacol; 2017 Apr; 31(2):136-146. PubMed ID: 27885718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome.
    Wang W; Hu D; Feng Y; Wu C; Song Y; Liu W; Li A; Wang Y; Chen K; Tian M; Xiao F; Zhang Q; Chen W; Pan P; Wan P; Liu Y; Lan H; Wu K; Wu J
    BMC Biol; 2020 Nov; 18(1):182. PubMed ID: 33243234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockage of P2X7 attenuates acute lung injury in mice by inhibiting NLRP3 inflammasome.
    Wang S; Zhao J; Wang H; Liang Y; Yang N; Huang Y
    Int Immunopharmacol; 2015 Jul; 27(1):38-45. PubMed ID: 25937482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.
    Baudelet D; Lipka E; Millet R; Ghinet A
    Curr Med Chem; 2015; 22(6):713-29. PubMed ID: 25515510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism.
    Al-Aqtash R; Collier DM
    Channels (Austin); 2024 Dec; 18(1):2355150. PubMed ID: 38762911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.